Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Principal Investigator
A Rapid Diagnostic of Risk in COVID-19 Patients to Improve Outcomes and Critical Resource Allocation Using Machine Learning
Manual Lymphatic Drainage
Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
Botulinum toxin: new option for refractory lower urinary tract symptoms in women.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Botulinum toxin: new option for refractory lower urinary tract symptoms in women.
Botulinum toxin: new option for refractory lower urinary tract symptoms in women. Clin Obstet Gynecol. 2008 Mar; 51(1):176-86.
View in:
PubMed
subject areas
Anti-Dyskinesia Agents
Botulinum Toxins
Drug Resistance
Female
Humans
Muscle Hypertonia
Pelvic Floor
Quality of Life
Safety
Treatment Outcome
Urinary Bladder, Overactive
Urinary Incontinence, Urge
authors with profiles
Kimberly Kenton